Schizoaffective Disorders Terminated Phase 2 Trials for Olanzapine (DB00334)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

DBCOND0033299 (Schizoaffective Disorders)Terminated2 IdentifierTitlePurposeDrugs
NCT02462473A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTreatment
NCT00734435Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsTreatment